HealthcarePress Releases

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Value – US$ 4.02 Bn By 2030

Share This Article

The global enzyme-linked immunosorbent assay (ELISA) testing market size is expected to reach US$ 4.02 billion by 2030, registering a CAGR of 6.4% from 2021 to 2030, as per reports by market research and consulting organisation Precedence Research.

The report contains 150+ pages with detailed analysis. The report provides an in-depth analysis of the market size, share, emerging and current trends, future estimations, and key players.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1260

Crucial factors accountable for market growth are:

  • Growing incidence of infectious disorders such as hepatitis, dengue, and AIDS
  • Increasing prevalence of neurological disorders
  • Growing geriatric population
  • High research and development expenditure of major players
  • Growing per capita healthcare spending
  • Growing incidence of non-communicable diseases
  • Emergence of cost-effective technologies

Competition Landscape

In the final section of the research report, Precedence Research provided the global enzyme-linked immunosorbent assay (ELISA) testing market structure and a detailed competition landscape to provide a dashboard view of key players operating in the enzyme-linked immunosorbent assay (ELISA) testing market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the enzyme-linked immunosorbent assay (ELISA) testing market include:

  • Thermo Fisher Scientific, Inc.
  • American Laboratory Products Company (ALPCO)
  • Bio-Rad Laboratories, Inc.
  • BD
  • BioMérieux SA
  • Ortho Clinical Diagnostics
  • R&D Systems, Inc.
  • ZEUS Scientific, Inc.

Market Report Scope

This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, the Middle East and Africa. This research report offers scenario and forecast (revenue/volume) and categorizes the market by key players and various segment. This report also studies global market prominence, competitive landscape, market share, growth rates market dynamics such as drivers, restraints and opportunities, and distributors and sales channels.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

COVID-19 Impact:

The services related to the prevention and treatment of non-communicable ailments has been significantly disrupted due to the COVID-19 pandemic, as per a survey published by the World Health Organization (WHO). The main result of the survey is that the healthcare facilities have been partly or entirely disrupted in many regions. Around 53% of the nations surveyed have witnessed partial or total disruption in hypertension treatment, 49% in diabetes treatment and other complications related to diabetes, 42% in treatment of cancer, and 31% in cardiovascular related emergencies. This condition is of significant worry because individuals living with non-communicable ailments are at greater risk of severe COVID-19 related sickness and mortality. Many individuals who need diagnosis for ailments like cardiovascular disease, cancer, tumor, and diabetes have faced difficulties in receiving the services and tests since the COVID-19 pandemic began.

Market Segmentation

By Test Type

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Competitive ELISA
  • Others

By Application

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Other Applications

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Most Asked Questions

  • What is the market size of the enzyme-linked immunosorbent assay (ELISA) testing market at the global level?
  • Which screen size is most preferred by the consumers of enzyme-linked immunosorbent assay (ELISA) testing?
  • Which mode of distribution channel is most preferred by the manufacturers of enzyme-linked immunosorbent assay (ELISA) testing?
  • Which is the preferred age group for targeting enzyme-linked immunosorbent assay (ELISA) testing for manufacturers?
  • Who are the major players operating in the global enzyme-linked immunosorbent assay (ELISA) testing market? What is the current market position of the key players? Who are the emerging players in this industry?
  • Who are the major distributors, traders, and dealers operating in the enzyme-linked immunosorbent assay (ELISA) testing market?
  • What the key factors driving, inhibiting the growth of the market, and what is the degree of impact of the drivers and restraints?
  • What is the impact of the regulations on the growth of the enzyme-linked immunosorbent assay (ELISA) testing market?
  • Which is the leading region/country for the growth of the market? What is the anticipated growth rate of the leading regions during the forecast period?
  • How are the emerging markets for enzyme-linked immunosorbent assay (ELISA) testing expected to perform in the coming years? How is the consumption pattern expected to evolve in the future?

Why should you invest in this report?

If you are aiming to enter the global enzyme-linked immunosorbent assay (ELISA) testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for enzyme-linked immunosorbent assay (ELISA) testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1260

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Test Type

7.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Test Type, 2021-2030

7.1.1. Sandwich ELISA

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Indirect ELISA

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Multiple and Portable ELISA

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Competitive ELISA

7.1.4.1. Market Revenue and Forecast (2017-2030)

7.1.5. Others

7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Application

8.1. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Application, 2021-2030

8.1.1. Immunology

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Inflammation

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Infectious diseases

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Cancer

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Protein quantification

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Other Applications

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Test (2017-2030)

9.1.2. Market Revenue and Forecast, by Application (2017-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Test (2017-2030)

9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Test (2017-2030)

9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Test (2017-2030)

9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Test (2017-2030)

9.5.2. Market Revenue and Forecast, by Application (2017-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Test (2017-2030)

9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Test (2017-2030)

9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

Chapter 10. Company Profiles

10.1. Thermo Fisher Scientific, Inc.

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. American Laboratory Products Company (ALPCO)

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Bio-Rad Laboratories, Inc.

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. BD

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. BioMérieux SA

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Ortho Clinical Diagnostics

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. R&D Systems, Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. ZEUS Scientific, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1260

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Follow us on LinkedIn | Twitter | Facebook

Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button